Clinical Effects of Long-term Administration of Pranlukast, a Leukotriene Receptor Antagonist, on Adult Patients with Bronchial Asthma

Arzneimittel-Forschung/Drug Research

Volumn 53, Issue 10, 2003, Pages 714-721

  Horiguchi, Takahiko ^a   Tachikawa, Soichi ^a   Kondo, Rieko ^a   Shiga, Mamoru ^a   Hirose, Masahiro ^a   Ito, Tomohiro ^a  

^a FUJITA HEALTH UNIVERSITY BANTANE HOSPITAL   (Japan)

Author keywords

Bronchial asthma; CAS 103177 37 3; Leukotriene receptor antagonist; Onon ; Pranlukast, long term administration, patients

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; EOSINOPHIL CATIONIC PROTEIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PRANLUKAST; STEROID;

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; EOSINOPHIL; EVALUATION; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE FACILITY; HEALTH CARE UTILIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; STATISTICAL ANALYSIS;

EID: 0242351948     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1299817     Document Type: Article

References (10)

1. Yamamoto, H., Nagata, M., Kuramitsu, K. et al., Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078. Am. J. Respir. Crit. Care Med. 150, 254 (1994)
2. Fujimura, M., Sakamoto, S., Kamio, Y. et al., Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma. Respir. Med. 87, 133 (1993)
3. 4 antagonists; Study of the effectiveness of ONO-1078 for adult bronchial asthma. Igaku No Ayumi 164, 225 (1993)
4. Kohrogi, H., Iwagoe, H., Fujii, K. et al., The role of cysteinyl leukotrienes in the pathogenesis of asthma: clinical study of leukotriene antagonist pranlukast for 1 year in moderate and severe asthma. Respirology 4, 319 (1999)
5. Makino, S., Miyamoto, T., Furusyo, K., Prevention of asthma: guideline for management in 1998. Kyowa Kikaku Tsushin, Tokyo (1998)
6. Christian Virchow, J., Prasse, A., Naya, I. et al., Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am. J. Respir. Crit. Care Med. 162, 578 (2000)
7. Laviolette, M., Malmstrom, K., Lu, S. et al., Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group. Am. J. Respir. Crit. Care Med. 160, 1862 (1999)
8. Tamaoki, J., Kondo, M., Sakai, N. et al., Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group. Am. J. Respir. Crit. Care Med. 155, 1235 (1997)
9. Horiguchi, T. et al., Evaluation of the combined effect of pranlukast during high-dose steroid inhalation. Arzneim.-Forsch/Drug Res. 53, 813 (2002)
10. Horiguchi, T., Tachikawa, S., Kasahara, J. et al., Effects of pranlukast hydrate on serum eosinophil cationic protein levels in patients with adult bronchial asthma. Arzneim.-Forsch./Drug Res. 49 (I), 35 (1999)